These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9676990)

  • 1. Genetic markers of increased susceptibility to diabetic nephropathy.
    Doria A
    Horm Res; 1998; 50 Suppl 1():6-11. PubMed ID: 9676990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
    Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
    DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.
    Baba T; Neugebauer S; Watanabe T
    Drugs; 1997 Aug; 54(2):197-234. PubMed ID: 9257079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].
    Buraczyńska M; Ksiazek P; Łopatyński J; Spasiewicz D; Nowicka T; Ksiazek A
    Pol Arch Med Wewn; 2002 Aug; 108(2):725-30. PubMed ID: 12476891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of diabetic nephropathy.
    Rippin JD; Patel A; Bain SC
    Best Pract Res Clin Endocrinol Metab; 2001 Sep; 15(3):345-58. PubMed ID: 11554775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of diabetic nephropathy.
    Chowdhury TA; Dyer PH; Kumar S; Barnett AH; Bain SC
    Clin Sci (Lond); 1999 Mar; 96(3):221-30. PubMed ID: 10029557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
    Tamura J; Konno A; Hashimoto Y; Kon Y
    Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetics of diabetic complications: nephropathy].
    Jeunemaitre X
    Ann Endocrinol (Paris); 2004 Feb; 65(1 Suppl):S10-6. PubMed ID: 15163919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Renin Angiotensin Aldosterone System Genes in Diabetic Nephropathy.
    Rahimi Z
    Can J Diabetes; 2016 Apr; 40(2):178-83. PubMed ID: 26619914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing end stage renal disease in diabetic patients--genetic aspect (part I).
    Jacobsen PK
    J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):1-14. PubMed ID: 16088846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of candidate genes' polymorphism in the development of diabetic nephropathy].
    Grzeszczak W; Zukowska-Szczechowska E
    Wiad Lek; 1998; 51 Suppl 2():11-23. PubMed ID: 9686528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene polymorphism of the renin-angiotensin system and progression of diabetic nephropathy.
    Orisio S
    J Nephrol; 1999; 12(1):9-17. PubMed ID: 10202997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants of diabetic renal disease and their impact on therapeutic interventions.
    Schmidt S; Ritz E
    Kidney Int Suppl; 1997 Dec; 63():S27-31. PubMed ID: 9407416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic factors with significance in pathogenesis of diabetic nephropathy--the role of polymorphism of renin-angiotensin system genes].
    Grzeszczak W
    Przegl Lek; 2000; 57 Suppl 3():19-24. PubMed ID: 11293230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.
    Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P
    Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic susceptibility to microangiopathy development in Type 1 diabetes mellitus].
    Corrêa-Giannella ML; Vieira SM
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):375-86. PubMed ID: 18438549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
    Marre M; Jeunemaitre X; Gallois Y; Rodier M; Chatellier G; Sert C; Dusselier L; Kahal Z; Chaillous L; Halimi S; Muller A; Sackmann H; Bauduceau B; Bled F; Passa P; Alhenc-Gelas F
    J Clin Invest; 1997 Apr; 99(7):1585-95. PubMed ID: 9120002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
    Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
    Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the renin-angiotensin system genes and diabetic nephropathy in the Chinese.
    Wu S; Xiang K; Zheng T; Sun D; Weng Q; Zhao H; Li J
    Chin Med J (Engl); 2000 May; 113(5):437-41. PubMed ID: 11776100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.